Txomin Arbizu

1.3k total citations
29 papers, 913 citations indexed

About

Txomin Arbizu is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Txomin Arbizu has authored 29 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Txomin Arbizu's work include Multiple Sclerosis Research Studies (15 papers), Peripheral Neuropathies and Disorders (5 papers) and Polyomavirus and related diseases (3 papers). Txomin Arbizu is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Peripheral Neuropathies and Disorders (5 papers) and Polyomavirus and related diseases (3 papers). Txomin Arbizu collaborates with scholars based in Spain, Sweden and Italy. Txomin Arbizu's co-authors include Francesc Graus, Isidró Ferrer, Joan Santamaría, Sergio Martínez‐Yélamos, J. B. Posner, John Newsom–Davis, B Lang, Antonio Martı́nez-Yélamos, Clifford B. Saper and Paul D. Clouston and has published in prestigious journals such as Neurology, Stroke and Medicine.

In The Last Decade

Txomin Arbizu

29 papers receiving 875 citations

Peers

Countries citing papers authored by Txomin Arbizu

Since Specialization

Citations

This map shows the geographic impact of Txomin Arbizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Txomin Arbizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Txomin Arbizu more than expected).

Fields of papers citing papers by Txomin Arbizu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Txomin Arbizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Txomin Arbizu. The network helps show where Txomin Arbizu may publish in the future.

Co-authorship network of co-authors of Txomin Arbizu

This figure shows the co-authorship network connecting the top 25 collaborators of Txomin Arbizu. A scholar is included among the top collaborators of Txomin Arbizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Txomin Arbizu. Txomin Arbizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PND23 Cost of the Informal Care of Multiple Sclerosis in Spain 2011 ·Value in Health ·(unknown), V. Casado, Lucía Romero, Elisabet Matas, Laura Bau, Sergio Martínez‐Yélamos, Txomin Arbizu	2
2	PND19 Cost Of The Relapse Of Multiple Sclerosis In Spain 2011 ·Value in Health ·(unknown), V. Casado, Lucía Romero, Elisabet Matas, Laura Bau, Sergio Martínez‐Yélamos, Montserrat López, Antonio Escartín, Txomin Arbizu	4
3	Apolipoprotein Alleles and the Response to Interferon-β-1b in Multiple Sclerosis 2011 ·European Neurology ·Olga Carmona, Cristina Masuet‐Aumatell, Pedro Alía, (unknown), Lucía Alonso-Magdalena, V. Casado, (unknown), Txomin Arbizu	6
4	Rhombencephalitis 2011 ·Medicine ·(unknown), Sergio Martínez‐Yélamos, Carles Majós, P Fernández-Viladrich, Francisco Rubio, Txomin Arbizu	55
5	International Development of the Unidimensional Fatigue Impact Scale (U-FIS) 2010 ·Value in Health ·Lynda Doward, David Meads, John D. Fisk, James Twiss, Peter Hagell, (unknown), François Grand’Maison, Virender Bhan, Txomin Arbizu, Thomas Kohlmann, David Brassat, (unknown), Stephen P. McKenna	18
6	International Development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS) 2010 ·Value in Health ·Stephen P. McKenna, Lynda Doward, James Twiss, Peter Hagell, (unknown), John D. Fisk, François Grand’Maison, Virender Bhan, Txomin Arbizu, David Brassat, Thomas Kohlmann, David Meads, (unknown)	24
7	Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis 2010 ·Journal of the Neurological Sciences ·Lucía Romero, Josep M. Pujal, Sergio Martínez‐Yélamos, (unknown), Elisabet Matas, Laura Bau, Marta Torrabadella, Carmen Azqueta, Txomin Arbizu	2
8	Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study 2010 ·BMC Neurology ·Virginia Devonshire, Txomin Arbizu, (unknown), Michael Lang, Alessandra Lugaresi, B. Singer, Elisabetta Verdun di Cantogno, Peter Cornelisse	43
9	Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study 2010 ·Multiple Sclerosis Journal ·Giancarlo Comi, Oded Abramsky, Txomin Arbizu, (unknown), Ralf Gold, Eva Havrdová, Sámuel Komoly, Krzysztof Selmaj, Basil Sharrack, Massimo Filippi, (unknown)	56
10	T cell subsets in multiple sclerosis: a serial study 2009 ·Acta Neurologica Scandinavica ·Matilde Calopa, Jordi Bas, M Mestre, Txomin Arbizu, (unknown), E. Buendía	3
11	Interferon-β<sub>1b</sub> in Multiple Sclerosis: Effect on Progression of Disability and Clinical Markers of Treatment Response 2008 ·European Neurology ·Olga Carmona, V. Casado, (unknown), Lucía Alonso-Magdalena, Antonio Martı́nez-Yélamos, Sergio Martínez‐Yélamos, (unknown), Txomin Arbizu	3
12	Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability 2006 ·BMC Health Services Research ·V. Casado, Sergio Martínez‐Yélamos, Antonio Martı́nez-Yélamos, Olga Carmona, Lucía Alonso, Lucía Romero, Esther Moral, (unknown), Txomin Arbizu	40
13	Effect of glatiramer acetate (Copaxone®) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study 2006 ·Neuroscience Letters ·Yolanda Blanco, Esther Moral, Meritxell Costa, Manuel Gómez‐Choco, Jesús F. Torres-Peraza, Lucía Alonso-Magdalena, Jordi Alberch, Dolores Jaraquemada, Txomin Arbizu, Francesc Graus, Albert Saiz	47
14	Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis 2004 ·Neuroscience Letters ·Antonio Martı́nez-Yélamos, Albert Saiz, Jordi Bas, (unknown), Francesc Graus, Txomin Arbizu	38
15	Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease 1998 ·Neuroscience Letters ·Jesús Aldudo, María J. Bullido, Txomin Arbizu, Rafael Oliva, Fernando Valdivieso	23
16	Clinical skills assessment with standardized patients 1997 ·Medical Education ·José María Gómez, Luís Prieto, Ramón Pujol, Txomin Arbizu, (unknown), (unknown), (unknown), (unknown), (unknown)	31
17	Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease 1997 ·Journal of Neuroimmunology ·Francesc Graus, Josep Dalmau, Francesc Valldeoriola, Isidró Ferrer, R. Reñé, Concepción Marín, Ch.J. Vecht, Txomin Arbizu, (unknown), (unknown)	135
18	Colonic pseudo-obstruction: a complication of herpes zoster 1996 ·British Journal of Dermatology ·Anna Jucglá, (unknown), Carlos García Ballesta, Txomin Arbizu	15
19	[Changes in the small cerebral vessels in the acquired immunodeficiency syndrome]. 1992 ·PubMed ·Xavier Ferrer, (unknown), Txomin Arbizu, (unknown), Ferrán Bolao, (unknown), (unknown)	1
20	A Golgi and ultrastructural study of a dominant form of Kufs' disease 1980 ·Journal of Neurology ·Isidró Ferrer, Txomin Arbizu, (unknown), (unknown)	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact